SCHEDULE 13G/A 0001373604-24-000105 0001373604 XXXXXXXX LIVE 1 Common Shares, no par value per share 12/31/2024 0001633932 ESSA Pharma Inc. 29668H708 Suite 720, 999 West Broadway Vancouver Z4 V5Z 1K5 Rule 13d-1(c) BML Investment Partners, L.P. b DE 0 4221546 0 4221546 4221546 N 9.5 PN This filing is being done to correct shares and percentage ownership. ESSA Pharma Inc. Suite 720, 999 West Broadway, Vancouver, Canada (Federal Level), V5Z 1K5 BML Investment Partners, L.P. 65 E Cedar, Suite 2, Zionsville, IN 46077 Delaware Y 4,221,546 9.5 0 4,221,546 0 4,221,546 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. BML Investment Partners, L.P. Braden M Leonard 02/14/2025 BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.